The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
News | Heart Failure | January 27, 2021
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation...
The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.
News | Peripheral Artery Disease (PAD) | January 26, 2021
January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug...
News | Stents Drug Eluting | January 26, 2021
January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-...
Sponsored Content
Feature | Wearables | December 15, 2020
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office...
News | Heart Failure | January 25, 2021
January 25, 2021 — The U.S. Food and Drug Administration (FDA) approved Merck's Verquvo (vericiguat). It is the first...
An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures.
Feature | Medical 3-D Printing | January 24, 2021 | By Dave Fornell, Editor
With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D...
Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images
Feature | Coronavirus (COVID-19) | January 22, 2021 | Dave Fornell, Editor
With nearly a year of experience with the COVID-19 (SARS-CoV-2) virus, it has been found that some post-COVID patients...
Sponsored Content
Case Study | Cardiovascular Information Systems (CVIS) | November 23, 2020
This Frost & Sullivan Executive White Paper explains that digitization is the shift to value-based care and risk-...
Getty Images
Blog | Coronavirus (COVID-19) | January 21, 2021
As of January 2021, in the United States we are now on month 10 of the COVID-19 pandemic. One year ago, we followed...
HeartSciences has been developing a new type of ECG system called Wavelet ECG that may offer a new way of looking at the heart. The MyoVista system uses continuous wavelet transform (CWT) signal processing to provide new frequency and energy information to detect cardiac relaxation abnormalities associated with left ventricular diastolic dysfunction commonly associated with hypertension, diabetes, valvular disease, ischemia and reduced systolic function. Artificial intelligence is used to read the nuances of these complex waveforms.
Feature | ECG | January 20, 2021 | By Dave Fornell, Editor
Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems. The...
News | Heart Valve Technology | January 20, 2021
January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage...
Sponsored Content
OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.
Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.
Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve...
Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at the 2020 Radiological Society of North America (RSNA) meeting. Getty Images
Feature | RSNA | January 18, 2021 | By Dave Fornell and Melinda Taschetta-Millane
Not surprisingly, many of the key trends observed at the 2020 Radiological Society of North America (RSNA) meeting...
Coronary CT angiography images courtesy of Canon Medical Systems.
News | CT Angiography (CTA) | January 18, 2021
January 18, 2020 — The Society of Cardiovascular Computed Tomography (SCCT), in collaboration with the North American...
Sponsored Content
Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.
Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images
News | Coronavirus (COVID-19) | January 18, 2021
January 18, 2021 — According to a new national survey released Jan. 13 by the Society for Cardiovascular Angiography...
The FineHeart Transcutaneous Energy Transfer (TET) System for the ICOMS cardiac assist device. 1. The ICOMS heart pump. 2. The implanted TET transfer pad. 3. The external energy transfer pad.
News | Heart Failure | January 13, 2021
January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist...
Myocarditis among recovering COVID-19 athletes appears to be less common than previously reported. Getty Images
News | Coronavirus (COVID-19) | January 12, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association (AHA) medical journal ...
